# Virtus Biotech Clinical Trials ETF (BBC) — Overview

BBC · NYSE · Fund

Canonical page: https://www.lighthorse.io/tickers/bbc

## Price

Last close $41.16 on Oct 15, 2026. 52-week range $29.23 – $56.03.

## Fund profile

BBC tracks an equally weighted index of US-listed biotech companies with lead drugs in various phases of clinical trials.

| Metric | Value |
| --- | --- |
| Issuer | Virtus Investment Advisers, LLC |
| Industry | Healthcare |
| Inception | Dec 16, 2014 |
| Assets under management | $38.1M |
| Expense ratio | 0.65% |
| Net asset value | $40.15 (as of Oct 14, 2026) |
| Distributions | Annually |
| Leverage | 1x |

## Frequently Asked Questions

### What is Virtus Biotech Clinical Trials ETF (BBC)?

BBC tracks an equally weighted index of US-listed biotech companies with lead drugs in various phases of clinical trials.

### What is BBC's expense ratio?

Virtus Biotech Clinical Trials ETF charges an annual expense ratio of 0.65%. The fund is issued by Virtus Investment Advisers, LLC.

### How large is BBC?

Virtus Biotech Clinical Trials ETF manages $38.1M in assets and has traded since Dec 16, 2014.

### How do I buy shares of Virtus Biotech Clinical Trials ETF (BBC)?

BBC trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).